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Introduction
Aspergillus spores are routinely inhaled. Innate immune defenses prevent 
fungal growth and disease in immunocompetent individuals. However, 
immunocompromised patients are at risk of developing invasive aspergillosis. 
Diagnosis of invasive aspergillus is often difficult as biopsy is not always 
feasible and relies on the interpretation of non-invasive testing. Early 
recognition and initiation of therapy is paramount as the mortality rate is high.
Case Presentation
Patient is a 59 year old female with a history of alcohol abuse admitted with 
acute encephalopathy and new onset seizure.
History: 
- Initially presented 3 weeks earlier for jaundice, found to have acute alcoholic 
hepatitis, started and discharged on prednisolone
- Now presenting with new onset grand mal seizure and acute confusion
- Obtunded on admission and admitted to the ICU
- Required intubation for airway protection
Admission Workup: 
Chest XR: Diffuse ground glass opacities bilaterally
Head CT: Patchy white matter foci in the left frontal and parietal
MRI Brain (Image 1): T2/FLAIR hyperintense lesions in frontal/parietal regions 
in a scattered distribution





Day 1: Started on Vancomycin and Zosyn. TEE with no vegetations. Unable 
to perform LP. Unable to liberate from mechanical ventilation
Day 4: Repeat MRI brain with increased size and number of lesions. Chest 
CT (Image 2): Multifocal air disease bilaterally with ill-defined left lower lobe 
density. Respiratory cultures growing aspergillus. Started on IV voriconazole
Day 8: Galactomannan and beta-D-glucan positive. Repeat head CT with 
increased CNS lesions. Transitioned to comfort care after family discussion.
Autopsy with multiple CNS fungal abscesses with leptomeningeal extension, 
consistent with disseminated aspergillosis





Neutropenia or neutrophil 
dysfunction (steroids) promotes 
hyphal growth and invasion
Image 1 Admission MRI with 
scattered T2/FLAIR enhanced 
lesions 
Radiographic Findings of Invasive Aspergillosis
Image 2 Chest CT (A/P) with 
multifocal opacities bilaterally
Fungal Biomarker Testing Characteristics
Sensitivity Specificity
Beta-D-Glucan (Serum) 77% 85%
Galactomannan (BAL) 88% 81%




When to Test for Invasive Fungal Infections
Testing for invasive fungal infection should be initiated promptly in all patients 
who have risk factors and the differential includes fungal etiology.
Radiographic Characteristics
Pulmonary Aspergillosis: 1. Single or multiple nodules (+/- cavitation) 2. 
Patchy/segmental consolidations 3. Peribronchial infiltrates (+/- tree-in-bud)
CNS Aspergillosis: 1. Ring-enhancing lesions 2. Cerebral cortical/subcortical 
infarction +/- hematoma 3. Sinus involvement with CNS extension
How to Interpret Fungal Biomarkers and Cultures
Beta-D-Glucan: Cell wall component in fungi. Found on all fugus and not 
specific for aspergillus. (+) test may indicate fungal infection, but not specific
Galactomannan: Polysaccharide on aspergillus walls. More specific for 
aspergillus and can be diagnostic in the correct context. Sensitivity decreased 
with antifungal therapy and false (+) can occur with Zosyn. If serum results 
are (-), BAL can be performed, which provides additional sensitivity.
Fungal Cultures: Does not always mean active infection. We are constantly 
inhaling conidia. (+) cultures need to be weighed again the probability of 
aspergillosis as the cause of disease. 
Biopsy is the gold standard, but often cannot be obtained in critical illness
- Invasive aspergillosis often presents with non-specific symptoms and knowing 
the risk factors and radiographic findings can help identify who to test 
- Diagnosis is based upon both identifying the organism via biopsy or 
biomarkers as well as probability that aspergillus is the cause of disease 
- Positive sputum fungal stain/culture or positive galactomannan should prompt 
therapy in the setting of high clinical suspicion and risk factors for aspergillosis 
Major Risk Factors for Invasive Aspergillosis
- Neutropenia  
- Steroid use
- Immunosuppression (transplant, 
AIDS, Immunosuppressive meds)
- Cirrhosis  - COPD 
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